Edition:
United Kingdom

Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

6.44USD
15 Dec 2017
Change (% chg)

$0.14 (+2.30%)
Prev Close
$6.30
Open
$6.28
Day's High
$6.56
Day's Low
$6.28
Volume
784,633
Avg. Vol
50,542
52-wk High
$9.78
52-wk Low
$5.75

Chart for

About

Veracyte, Inc. is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. It targets diseases in which patients undergo invasive diagnostic procedures. Its products combine genomic technology, clinical science and machine learning. The Company commercializes over three genomic tests,... (more)

Overall

Beta: 1.93
Market Cap(Mil.): $312.50
Shares Outstanding(Mil.): 33.89
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Veracyte posts Q3 loss per share $0.21

* Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S

06 Nov 2017

BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA

* Veracyte Inc - reimbursement rate for Afirma Genomic Classifier is expected to increase from $3,220 to $3,600 for calendar year 2018

25 Sep 2017

Earnings vs. Estimates